These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15595185)

  • 1. Biosensor alternative: frontal affinity chromatography.
    Schriemer DC
    Anal Chem; 2004 Dec; 76(23):440A-448A. PubMed ID: 15595185
    [No Abstract]   [Full Text] [Related]  

  • 2. Frontal affinity chromatography-mass spectrometry assay technology for multiple stages of drug discovery: applications of a chromatographic biosensor.
    Chan NW; Lewis DF; Rosner PJ; Kelly MA; Schriemer DC
    Anal Biochem; 2003 Aug; 319(1):1-12. PubMed ID: 12842101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular recognition of cocaine by acetylcholinesterases for affinity purification and bio-sensing.
    Knösche K; Halámek J; Makower A; Fournier D; Scheller FW
    Biosens Bioelectron; 2004 Sep; 20(2):153-60. PubMed ID: 15308216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding of caffeic acid to human serum albumin by the retention data and frontal analysis.
    An Y; Li Q; Chen J; Gao X; Chen H; Xiao C; Bian L; Zheng J; Zhao X; Zheng X
    Biomed Chromatogr; 2014 Dec; 28(12):1881-6. PubMed ID: 24828401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of isothermal adsorption of albumin on acetate fiber filter rod with dye affinity ligand.
    Li JH; Wang JD; Liu XL
    Se Pu; 2002 Sep; 20(5):419-22. PubMed ID: 16358692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated detection of covalent adducts to human serum albumin by immunoaffinity chromatography, on-line solution phase digestion and liquid chromatography-mass spectrometry.
    Hoos JS; Damsten MC; de Vlieger JS; Commandeur JN; Vermeulen NP; Niessen WM; Lingeman H; Irth H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Nov; 859(2):147-56. PubMed ID: 17913598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optical biosensor techniques to analyze protein-polysaccharide interactions.
    Fernig DG
    Methods Mol Biol; 2001; 171():505-18. PubMed ID: 11450264
    [No Abstract]   [Full Text] [Related]  

  • 8. Emerging affinity methods for protein-drug interaction analysis.
    Zheng X; Zhu H; Zhao X; Wang J; Li Q; Zhao X
    J Pharm Biomed Anal; 2024 Oct; 249():116371. PubMed ID: 39047466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput screening for enzyme inhibitors using frontal affinity chromatography with liquid chromatography and mass spectrometry.
    Ng ES; Yang F; Kameyama A; Palcic MM; Hindsgaul O; Schriemer DC
    Anal Chem; 2005 Oct; 77(19):6125-33. PubMed ID: 16194069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of biosensors for microaffinity purification: an integrated approach to proteomics.
    Catimel B; Rothacker J; Nice E
    J Biochem Biophys Methods; 2001 Oct; 49(1-3):289-312. PubMed ID: 11694286
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of plasmatic acceptors as specific ligands in affinity chromatography cleanup of veterinary drugs from biological matrices.
    Gallo P; Nasi A; Vinci F; Fiori M; Brambilla G; Serpe L
    Anal Bioanal Chem; 2008 Jun; 391(4):1153-62. PubMed ID: 18193407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection of ligands for affinity chromatography using quartz crystal biosensor.
    Liu Y; Tang X; Liu F; Li K
    Anal Chem; 2005 Jul; 77(13):4248-56. PubMed ID: 15987134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated multiple ligand screening by frontal affinity chromatography-mass spectrometry (FAC-MS).
    Ng W; Dai JR; Slon-Usakiewicz JJ; Redden PR; Pasternak A; Reid N
    J Biomol Screen; 2007 Mar; 12(2):167-74. PubMed ID: 17218664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing a drug's primary binding site on albumin.
    Day YS; Myszka DG
    J Pharm Sci; 2003 Feb; 92(2):333-43. PubMed ID: 12532383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontal affinity chromatography with MS detection of the ligand binding domain of PPARγ receptor: ligand affinity screening and stereoselective ligand-macromolecule interaction.
    Calleri E; Fracchiolla G; Montanari R; Pochetti G; Lavecchia A; Loiodice F; Laghezza A; Piemontese L; Massolini G; Temporini C
    J Chromatogr A; 2012 Apr; 1232():84-92. PubMed ID: 22056242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating carbohydrate-protein binding interactions using frontal affinity chromatography coupled to mass spectrometry.
    Palcic MM; Zhang B; Qian X; Rempel B; Hindsgaul O
    Methods Enzymol; 2003; 362():369-76. PubMed ID: 12968377
    [No Abstract]   [Full Text] [Related]  

  • 17. Application of frontal affinity chromatography with mass spectrometry (FAC-MS) for stereospecific ligand-macromolecule interaction, detection and screening.
    Slon-Usakiewicz JJ; Redden P
    Methods Mol Biol; 2009; 572():219-30. PubMed ID: 20694695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of drug binding to human serum albumin by cholecystographic agents.
    Bertucci C; Cimitan S
    Farmaco; 2003 Sep; 58(9):901-8. PubMed ID: 13679185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
    Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
    J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an immobilized GPR17 receptor stationary phase for binding determination using frontal affinity chromatography coupled to mass spectrometry.
    Temporini C; Ceruti S; Calleri E; Ferrario S; Moaddel R; Abbracchio MP; Massolini G
    Anal Biochem; 2009 Jan; 384(1):123-9. PubMed ID: 18835238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.